5 Reasons Lululemon Stock Can Bounce Back

Lululemon Athletica is the S&P 500's worst-performing stock this year, down 56% YTD, after slashing its full-year EPS guidance from $14.58-$14.78 to $12.77-$12.97. This underperformance stems from the removal of the de minimis import exemption and a perceived staleness in product categories like lounge and social. Despite these challenges, management is implementing strategic overhauls, including a faster go-to-market approach and increasing new styles, with expected improvements by 2026. The company also benefits from robust international growth, particularly a 25% revenue increase in China, continued global store expansion, and its current valuation at a forward P/E of approximately 13, the lowest ever, suggesting potential for recovery.

Analysis

Lululemon Athletica (LULU) has become the S&P 500's worst performer, with its stock falling 56% year-to-date, punctuated by a 19% drop following its latest earnings report. The primary catalyst for this decline was a significant downward revision of its full-year EPS guidance from a range of $14.58-$14.78 to $12.77-$12.97. This revision stems from both external and internal pressures; externally, the removal of the de minimis import exemption has disrupted its U.S. e-commerce supply chain from Canada, while internally, management has acknowledged product staleness and a 4% decline in comparable sales in the Americas. In response, leadership is accelerating its go-to-market strategy and plans to increase new product styles from 23% to 35% by next spring, though results from these initiatives are not expected until 2026. Despite U.S. headwinds, the international segment remains a bright spot, with comparable sales up 15%, driven by a 25% revenue surge in China. The company also continues its physical expansion, adding 63 stores in the past year. Consequently, the stock now trades at a historically low forward price-to-earnings ratio of approximately 13, a valuation that reflects significant market pessimism but may present a deep-value opportunity if the strategic turnaround succeeds.

Key Decisions for Investors

• Investors should recognize that management has set a 2026 timeline for strategic initiatives to yield results, suggesting a recovery thesis requires a long-term investment horizon and patience through near-term volatility.
• Consider the historically low forward P/E of approximately 13 as a potential entry point, but weigh this against significant execution risks, including declining comparable sales in the Americas and the ongoing product and supply chain overhaul.
• Closely monitor upcoming earnings reports for improvement in Americas comparable sales, progress on the announced increase in new product styles, and sustained double-digit growth in the China market to validate the recovery narrative.
• Given the stock's significant underperformance and operational headwinds, any position should be viewed as a contrarian play, requiring careful risk management until tangible signs of a U.S. business turnaround emerge.